Allergic and non-allergic hypersensitivity reactions to toxoid-containing vaccines;Les réactions d'hypersensibilité allergique et non allergique aux vaccins contenant des anatoxines

Archives de Pediatrie

Volumn 16, Issue 4, 2009, Pages 391-395

  Ponvert, C ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BOOSTIX; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA VACCINE; DIPLOID CELL VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PENTAVAC; REPEVAC; REVAXIS; TETANUS TOXOID; TETRAVAC; UNCLASSIFIED DRUG; VACCINE;

ALLERGY; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTIBODY SPECIFICITY; ARTHUS PHENOMENON; ARTICLE; CLINICAL ASSESSMENT; DELAYED HYPERSENSITIVITY; DESENSITIZATION; HUMAN; HYPERSENSITIVITY REACTION; INFLAMMATION; INJECTION SITE REACTION; PREDICTION; SKIN TEST; URTICARIA;

HUMANS; HYPERSENSITIVITY; TOXOIDS; VACCINATION;

EID: 62349121532     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2009.01.002     Document Type: Article

References (36)

1. Bohlke K., Davis R.L., Marcy S.M., et al. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics 112 (2003) 815-820
2. Bults M., Kemmeren J.M., and Van der Maas N.A.T. Adverse events following booster doses of diphteria-tetanus-inactivated polio virus and acellular pertussis vaccines for 4-year-old children. Vaccine 25 (2007) 5272-5277
3. Carrasco-Garrido P., Gallardo-Pino C., Jiménez-Garcia R., et al. Incidence of adverse reactions to vaccines in a pediatric population. Clin Drug Invest 24 (2004) 457-463
4. Zent O., Arras-Reiter C., Broeker M., et al. Immediate allergic reactions after vaccination. A post-marketing surveillance review. Eur J Pediatr 161 (2002) 21-25
5. Gold M., Goodwin H., Botham S., et al. Revaccination of 421 children with a past history of an adverse reaction in a special immunization service. Arch Dis Child 83 (2000) 128-131
6. Ponvert C., Scheinmann P., Karila C., et al. L'allergie aux vaccins associés chez l'enfant : une étude de 30 cas fondée sur les tests cutanés à lecture immédiate, semi-retardée et retardée, sur les dosages des anticorps spécifiques et sur les injections de rappel. Rev Fr Allergol Immunol Clin 41 (2001) 701-711
7. Jacobs R.L., Lowe R.S., and Lanier B.Q. Adverse reactions to tetanus toxoid. J Am Med Assoc 247 (1982) 40-42
8. Bergfors E., Trollfors B., and Inerot A. Unexpectedly high incidence of persistent itching nodules and delayed hypersensitivity to aluminium in children after the use of adsorbed vaccines from a single manufacturer. Vaccine 22 (2003) 64-69
9. Netterlid E., Bruze M., Hindsén M., et al. Persistent itching nodules after the fourth dose of diphtheria-tetanus toxoid vaccines without evidence of delayed hypersensitivity to aluminium. Vaccine 22 (2004) 3698-3706
10. Church J.A., and Richard W. Recurrent abscess formation following DTP immunizations: Association with hypersensitivity to tetanus toxoid. Pediatrics 75 (1985) 899-900
11. Lehman H.K., Faden H.S., Fang Y.V., et al. A case of recurrent sterile abscesses following vaccination: Delayed hypersensitivity to aluminium. J Pediatr 152 (2008) 133-135
12. Cox N.H., Moss C., and Forsyth A. Allergy to non-toxoid constituents of vaccines and implications for patch testing. Contact Derm 18 (1988) 143-146
13. Mallet E., Fabre P., Pines E., et al. Immunogenicity and safety of a new liquid hexavalent combined vaccine compared with separate administration of reference licensed vaccines in infants. Pediatr Infect Dis 19 (2000) 119-127
14. Southern J., Andrews N., Burrage M., et al. Immunogenicity and reactogenicity of combined acellular pertussis/tetanus/low dose diphtheria vaccines given as a booster to UK teenagers. Vaccine 23 (2005) 3829-3835
15. Facktor M.A., Bernstein R.A., and Fireman P. Hypersensitivity to tetanus toxoid. J Allergy Clin Immunol 52 (1973) 1-12
16. Cryz S.J. Bacterial vaccines. In: Cryz S.J. (Ed). Immunotherapy and vaccines (1991), VCH, Wenheim 13-75
17. Scheifele D.W., Meekison W., Grace M., et al. Adverse reactions to the preschool (fifth) dose of adsorbed diphtheria-pertussis-tetanus vaccine in canadian children. Can Med Assoc J 145 (1991) 641-647
18. Rennels M.B., Deloria M.A., Pichichero M.E., et al. Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines. Pediatrics 105 (2000) e12-e18
19. Rennels M.R., Deloria M.A., Pichichero M.E., et al. Lack of consistent relationship between quantity of aluminium in diphtheria-tetanus-acellular pertussis vaccines and rates of extensive swelling reactions. Vaccine 20 (2002) 44-547
20. Skowronski D.M., Remple V.P., Macnabb J., et al. Injection-site reactions to booster doses of acellular pertussis vaccine: Rate, severity, and anticipated impact. Pediatrics 112 (2003) e453-e459
21. Gold M.S., Noonan S., Osbourn M., et al. Local reactions after the fourth dose of acellular pertussis vaccine in South Australia. Med J Aust 179 (2003) 191-194
22. Delafuente J.C., Eisenberg J.D., Moelzer D.R., et al. Tetanus toxoid as an antigen for delayed cutaneous hypersensitivity. J Am Med Assoc 249 (1983) 3209-3211
23. Fairschter R.D., Thornton D.B., Gottschalk H.R., et al. In vivo and in vitro cell-mediated immunity to tetanus toxoid in adults. J Allergy Clin Immunol 66 (1980) 452-457
24. Wood R.A., Setse R., and Halsey N. Irritant skin test reactions to common vaccines. J Allergy Clin Immunol 120 (2007) 478-481
25. Durand C., Pineau A., Bureau B., et al. Complications cutanées des vaccinations diphtérie, tétanos, coqueluche, poliomyélite (Tetracoq) : rôle de l'hydroxyde d'aluminium. Nouv Dermatol 11 (1992) 523-526
26. Slater D.N., Underwood J.C.E., Durrant T.E., et al. Aluminium hydroxide granulomas: light and electron microscopic studies and X-ray microanalysis. Brit J Dermatol 107 (1982) 103-108
27. Pembroke A.C., and Marten R.H. Unusual cutaneous reactions following diphtheria and tetanus immunization. Clin Exp Dermatol 4 (1979) 345-348
28. Carey A.B., and Meltzer E.O. Diagnosis and "desensitisation" in tetanus vaccine hypersensitivity. Ann Allergy 69 (1992) 336-338
29. Lewis K., Jordan S.C., Cherry J.D., et al. Petechiae and urticaria after DTP vaccination: detection of circulating immune complexes containing vaccine-specific antigens. J Pediatr 109 (1986) 1009-1012
30. Skov P.S., Pelck I., Ebbesen F., et al. Hypersensitivity to the diphtheria component in the Di-Te-Pol vaccine: a type I allergic reaction demonstrated by basophil histamine release. Pediatr Allergy Immunol 8 (1997) 156-158
31. Aalberse R.C., van Ree R., Danneman A., et al. IgE antibodies to tetanus toxoid in relation to atopy. Int Arch Allergy Immunol 107 (1995) 169-171
32. Dannemann A., van Ree R., Kulig M., et al. Specific IgE and IgG4 immune responses to tetanus and diphtheria toxoids in atopic and non atopic children during the first two years of life. Int Arch Allergy Immunol 111 (1996) 262-267
33. Nagel J., Svec D., Waters T., et al. IgE synthesis in man. I. Development of specific IgE antibodies after immunization with tetanus-diphteria (Td) toxoids. J Immunol 118 (1977) 334-341
34. Cody C.I., Baraff U., and Cherry J.D. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics 68 (1981) 650-660
35. Nakayama T., Aizawa C., and Kuno-Sakai H. A clinical analysis of gelatine allergy and determination of its causal relationship to the previous administration of gelatine-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids. J Allergy Clin Immunol 103 (1999) 321-325
36. Pittman P.R. Aluminium-containing vaccine associated adverse events: role of route of administration and gender. Vaccine 20 (2002) S48-50